A German medical device and services company agreed to settle charges of violating the anti-bribery, books and records, and internal accounting controls provisions of the Foreign Corrupt Practices Act.
Global medical device manufacturer Zimmer Biomet Holdings, Inc. settled criminal and civil charges brought by the DOJ and SEC after the company was found to have violated a 2012 agreement settling previous Foreign Corrupt Practices Act allegations.
FinCEN issued an advisory regarding changes to the lists of jurisdictions with strategic Anti-Money Laundering and Counter-Terrorist Financing ("AML/CFT") deficiencies. The lists were compiled by the Financial Action Task Force ("FATF"). The changes affect the due diligence obligations of U.S...
Request delivery of the Cadwalader Cabinet Newsletter.